NORTHWEST BIOTHERAPEUTICS INC (NWBO)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, NORTHWEST BIOTHERAPEUTICS INC reported revenue of $1.38M, down 0.3% from the prior year. The company ran a net loss, with a net margin of -4365.9%. It held $81.29M in total assets against $128.86M in total liabilities.
Key ratios (FY2025)
-4347.9%
Operating margin
-4365.9%
Net margin
-0.3%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.38M | $1.38M | $1.93M | — | — | — | — | — | — | — |
| Operating Income | -$59.91M | -$66.51M | -$55.51M | -$67.18M | -$52.70M | -$86.61M | -$27.98M | -$41.48M | -$54.68M | -$79.27M |
| Net Income | -$60.16M | -$83.78M | -$62.60M | -$105.03M | $179.13M | -$529.82M | -$20.81M | -$35.79M | -$73.14M | -$80.21M |
| EPS (Diluted) | $-0.04 | $-0.07 | $-0.06 | $-0.10 | $0.21 | $-0.73 | $-0.04 | — | — | — |
| Total Assets | $81.29M | $26.73M | $27.86M | $31.32M | $40.16M | $32.90M | $10.64M | $24.67M | $48.91M | $52.91M |
| Total Liabilities | $128.86M | $105.71M | $74.92M | $136.37M | $164.15M | $395.85M | $55.70M | $71.83M | $96.20M | $79.41M |
| Shareholders' Equity | -$60.28M | -$94.49M | -$65.77M | -$128.10M | -$123.99M | -$362.95M | -$45.05M | -$48.13M | -$67.33M | -$26.50M |
| Cash & Equivalents | $3.04M | $2.17M | $2.13M | $6.96M | $15.17M | $9.98M | $372.0K | $22.22M | $117.0K | $6.87M |
| Operating Cash Flow | -$44.76M | -$57.02M | -$53.64M | -$52.77M | -$38.30M | -$32.09M | -$31.86M | -$34.59M | -$36.49M | -$55.65M |
| Capital Expenditures | $1.50M | $1.01M | — | — | — | — | $171.0K | — | — | — |
| Shares Outstanding | 1.56B | 1.33B | 1.18B | 1.07B | 948.40M | 829.60M | 614.30M | 523.20M | 328.90M | 157.00M |